117 related articles for article (PubMed ID: 38678629)
1. LncRNA DDX11-AS1 promotes cell growth, migration and invasion through regulating epithelial-mesenchymal transition in breast cancer.
Xi X; Yang F; Ding Z; Zhuang H; Yuan H
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):40-44. PubMed ID: 38678629
[TBL] [Abstract][Full Text] [Related]
2. LncRNA DDX11 antisense RNA 1 promotes EMT process of esophageal squamous cell carcinoma by sponging miR-30d-5p to regulate SNAI1/ZEB2 expression and Wnt/β-catenin pathway.
Guo Y; Sun P; Guo W; Yin Q; Han J; Sheng S; Liang J; Dong Z
Bioengineered; 2021 Dec; 12(2):11425-11440. PubMed ID: 34866524
[TBL] [Abstract][Full Text] [Related]
3. LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer.
Yu DJ; Li YH; Zhong M
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4800-4806. PubMed ID: 31210311
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
5. The long non-coding RNA DDX11-AS1 facilitates cell progression and oxaliplatin resistance via regulating miR-326/IRS1 axis in gastric cancer.
Song W; Qian Y; Zhang MH; Wang H; Wen X; Yang XZ; Dai WJ
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3049-3061. PubMed ID: 32271422
[TBL] [Abstract][Full Text] [Related]
6. LncRNA DDX11-AS1 Promotes Chemoresistance through LIN28A-Mediated ATG12 mRNA Stabilization in Breast Cancer.
Si X; Zhang G; Li M; Yao M; Shi X; Dong Z; Gao S
Pharmacology; 2023; 108(1):61-73. PubMed ID: 36382664
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer.
Yang J; Wu W; Wu M; Ding J
In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061
[TBL] [Abstract][Full Text] [Related]
8. LncRNA NR2F1-AS1 promotes proliferation and metastasis of ESCC cells via regulating EMT.
Ren P; Zhang H; Chang L; Hong XD; Xing L
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3686-3693. PubMed ID: 32329844
[TBL] [Abstract][Full Text] [Related]
9. LncRNA
Chen D; Chen J; Gao J; Zhang Y; Ma Y; Wei W; Wei Y
Cancer Biother Radiopharm; 2020 Jun; 35(5):319-328. PubMed ID: 32412777
[No Abstract] [Full Text] [Related]
10. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
12. DDX11-AS1exacerbates bladder cancer progression by enhancing CDK6 expression via suppressing miR-499b-5p.
Li Q; Wang S; Wu Z; Liu Y
Biomed Pharmacother; 2020 Jul; 127():110164. PubMed ID: 32422563
[TBL] [Abstract][Full Text] [Related]
13. LncRNA DDX11-AS1 accelerates hepatocellular carcinoma progression via the miR-195-5p/MACC1 pathway.
Wan T; Zheng J; Yao R; Yang S; Zheng W; Zhou P
Ann Hepatol; 2021; 20():100258. PubMed ID: 32961346
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression.
Huang H; Yang C; Zhang Q; Zhuo T; Li X; Li N; Zhu L; Luo C; Gan J; Wu Y
Bioengineered; 2022 Mar; 13(3):4964-4977. PubMed ID: 35164653
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of LncRNA FAM83H-AS1 in hepatocellular carcinoma promotes cell proliferation, migration and invasion by Wnt/β-catenin pathway.
Ma YK; Shen TH; Yang XY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7855-7862. PubMed ID: 31599410
[TBL] [Abstract][Full Text] [Related]
16. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA DDX11-AS1 promotes esophageal carcinoma cell proliferation and migration through regulating the miR-514b-3p/RBX1 axis.
Wu C; Wang Z; Tian X; Wang J; Zhang Y; Wu B
Bioengineered; 2021 Dec; 12(1):3772-3786. PubMed ID: 34281459
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA MIF-AS1 promotes breast cancer cell proliferation, migration and EMT process through regulating miR-1249-3p/HOXB8 axis.
Ding J; Wu W; Yang J; Wu M
Pathol Res Pract; 2019 Jul; 215(7):152376. PubMed ID: 31097355
[TBL] [Abstract][Full Text] [Related]
20. LncRNA ITGB2-AS1 Could Promote the Migration and Invasion of Breast Cancer Cells through Up-Regulating ITGB2.
Liu M; Gou L; Xia J; Wan Q; Jiang Y; Sun S; Tang M; He T; Zhang Y
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29941860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]